127 related articles for article (PubMed ID: 6868226)
1. Management of patients with concurrent primary tumors of bladder and prostate.
Selli C; Hinshaw W; Wolfe JA; Paulson DF
Urology; 1983 Jun; 21(6):562-5. PubMed ID: 6868226
[TBL] [Abstract][Full Text] [Related]
2. Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder.
Pritchett TR; Moreno J; Warner NE; Lieskovsky G; Nichols PW; Cook BA; Skinner DG
J Urol; 1988 Jun; 139(6):1214-6. PubMed ID: 3373591
[TBL] [Abstract][Full Text] [Related]
3. Coexisting adenocarcinoma of prostate in patients undergoing cystoprostatectomy for bladder cancer.
Winfield HN; Reddy PK; Lange PH
Urology; 1987 Aug; 30(2):100-1. PubMed ID: 3617289
[TBL] [Abstract][Full Text] [Related]
4. Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy.
Reese JH; Freiha FS; Gelb AB; Lum BL; Torti FM
J Urol; 1992 Jan; 147(1):92-5. PubMed ID: 1729557
[TBL] [Abstract][Full Text] [Related]
5. Importance of early treatment of transitional cell carcinoma of prostatic ducts.
Wishnow KI; Ro JY
Urology; 1988 Jul; 32(1):11-2. PubMed ID: 3388655
[TBL] [Abstract][Full Text] [Related]
6. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
[TBL] [Abstract][Full Text] [Related]
7. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
8. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
[TBL] [Abstract][Full Text] [Related]
9. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous presentation of adenocarcinoma of prostate and transitional cell carcinoma of bladder.
Konski A; Rubin P; DiSantangnese PA; Mayer E; Keys H; Cockett A; Frank I; Davis R; Lush C
Urology; 1991 Mar; 37(3):202-6. PubMed ID: 2000674
[TBL] [Abstract][Full Text] [Related]
11. Commentary on prostate and urothelial carcinoma in cystoprostatectomy specimens.
Lotan Y
J Urol; 2008 May; 179(5 Suppl):S33-4. PubMed ID: 18405746
[No Abstract] [Full Text] [Related]
12. Editorial comment to characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy.
Szarvas T
Int J Urol; 2013 Sep; 20(9):872. PubMed ID: 23379970
[No Abstract] [Full Text] [Related]
13. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens.
Richards KA; Parks GE; Badlani GH; Kader AK; Hemal AK; Pettus JA
Urology; 2010 May; 75(5):1116-20. PubMed ID: 20080289
[TBL] [Abstract][Full Text] [Related]
14. Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy.
Buse S; Höfner T; Müller SC; Hermann E; Wieland WF; May M; Stief CG; Bastian PJ; Hohenfellner M; Haferkamp A
Int J Urol; 2013 Sep; 20(9):866-71. PubMed ID: 23379929
[TBL] [Abstract][Full Text] [Related]
15. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
[TBL] [Abstract][Full Text] [Related]
16. Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.
Wood DP; Montie JE; Pontes JE; VanderBrug Medendorp S; Levin HS
J Urol; 1989 Feb; 141(2):346-9. PubMed ID: 2913357
[TBL] [Abstract][Full Text] [Related]
17. The management of transitional cell carcinoma in the prostate.
Wolfe JH; Lloyd-Davies RW
Br J Urol; 1981 Jun; 53(3):253-7. PubMed ID: 7248704
[TBL] [Abstract][Full Text] [Related]
18. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
[TBL] [Abstract][Full Text] [Related]
19. Incidental prostate cancer: the importance of complete prostatic removal at cystoprostatectomy for bladder cancer.
Abbas F; Biyabani SR; Pervez S
Urol Int; 2000; 64(1):52-4. PubMed ID: 10782037
[TBL] [Abstract][Full Text] [Related]
20. Editorial comment.
Skinner EC
Urology; 2010 May; 75(5):1120; author reply 1120-1. PubMed ID: 20451729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
